-
-
-
-
-
-
-
UBS Reiterates Buy Rating on CVS Health (CVS) Despite Recent Stock Weakness
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
-
-
-
-
-
-
-
CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
-
-
-
-
-
-
-
CVS Health (CVS) Declares $.665 Quarterly Dividend; 2.6% Yield
-
-
-
-
-
-
-
CVS Health expands partnership with Salesforce for AI call centers
-
-
-
-
-
-
-
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications With Expanded Coverage Options
-
-
-
-
-
-
-
CVS Health (CVS) Caremark Delivers Expanded Coverage Options for GLP-1 Weight Management Medications
-
471,689 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

